why choose us

Clinical Trials Search

Showing 14,800 of 132,656 result(s)
A Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2086 in Healthy Adult and Elderly Participants

Status: Completed

Condition: Healthy Volunteers

Interventions: E2086 tablets.

Date: 2023-02-16

Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia

Status: Completed

Condition: Chronic Kidney Diseases

Interventions: DISC-0974 is administered subcutaneously

Date: 2023-02-16

An Evaluation of Hip Preservation Outcomes

Status: Completed

Condition: Hip Arthroscopy

Interventions: Hip Preservation surgeries

Date: 2023-02-16

Identification and Prevention of Pelvic Floor Dysfunction in Gynecologic Cancer Survivors

Status: Completed

Condition: Gynecologic Cancer

Interventions: The exam takes approximately 5 minutes and uses a single digit to palpate the pelvic floor muscles, during which patients will rate pain on a scale of

Date: 2023-02-16

Fetoscopic Endoluminal Tracheal Occlusion

Status: Completed

Condition: Hernia, DIaphragmatic, Congenital

Interventions: placement of FETO prior to 29 weeks 6 days GA; and removal of the FETO device no later than 35 weeks and 6 days

Date: 2023-02-16

Yoga for Adolescent Idiopathic Scoliosis (AIS) Patients

Status: NOT_YET_RECRUITING

Condition: Adolescent Idiopathic Scoliosis

Interventions: 6 yoga videos to be done 2-3x a week for 6 weeks before and after surgery.

Date: 2023-02-16

Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)

Status: Completed

Condition: Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)

Interventions: The BBP-418 drug product is provided as Granules for Oral solution consisting of BBP-418 drug substance and silicon dioxide in a multilaminate sachet

Date: 2023-02-16

A Study of Camizestrant in ER+;HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Status: Completed

Condition: Breast Cancer, Early Breast Cancer

Interventions: Camizestrant.
Experimental.
Administered orally

Date: 2023-02-16

(89Zr Panitumumab) With PET;CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

Status: Completed

Condition: Head and Neck Squamous Cell Carcinoma

Interventions: Given IV

Date: 2023-02-16

Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO17)

Status: ACTIVE_NOT_RECRUITING

Condition: Hypoxia

Interventions: OLV-4202 pulse oximeter (SW version: 01-15)

Date: 2023-02-16